ESC Professional Premium Access

In a large dataset of primary care patients, use of CHA2DS2-VA score leads to almost universal recommendation for anticoagulation in those aged 65 years and over with atrial fibrillation

Congress Presentation

About the speaker

Doctor Jessica Orchard

University of Sydney, Sydney (Australia)
3 presentations
0 follower

7 more presentations in this session

Including measures of chronic kidney disease to improve cardiovascular risk prediction by SCORE2 and SCORE2-OP

Speaker: Doctor S. Hageman (Utrecht, NL)


Potential impact of replacing SCORE with SCORE-2 on risk classification and statin eligibility - a coronary calcium score correlation study

Speaker: Miss M. Paiva (Lisbon, PT)


Associations of SCORE2, circulating cardiovascular biomarkers and carotid intima-media-thickness in a population-based cohort

Speaker: Doctor B. Toprak (Hamburg, DE)


Comparison between the European SCORE and the updated SCORE2 for cardiovascular outcomes

Speaker: Doctor M. Temtem (Funchal, PT)


Distribution of cardiovascular disease risk according to SCORE2 and potential need for cholesterol and blood pressure lowering therapy in apparently healthy middle-aged individuals

Speaker: Doctor A. Yari (Stockholm, SE)


Access the full session

Cardiovascular risk assessment and scores

Speakers: Doctor J. Orchard, Doctor S. Hageman, Miss M. Paiva, Doctor B. Toprak, Doctor M. Temtem...

About the event


ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb